NCT00101647 - Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia | Biotech Hunter

Enrollment

197

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

March 31, 2008

Conditions

Chronic Myelogenous Leukemia

Interventions

DRUG

Dasatinib

Tablets, Oral, 70 mg, twice daily, until disease progression or intolerable toxicity, switch to the roll-over study or study closure

Trial Locations (70)

Unknown

Local Institution, Birmingham

Local Institution, Anaheim

Local Institution, Los Angeles

Local Institution, Stanford

Local Institution, Vallejo

Local Institution, Jacksonville

Local Institution, Tampa

Local Institution, Atlanta

Local Institution, Chicago

Local Institution, Kansas City

Local Institution, Baltimore

Local Institution, Boston

Local Institution, Detroit

Local Institution, St Louis

Local Institution, Hackensack

Local Institution, New York

Local Institution, Portland

Local Institution, Pittsburgh

Local Institution, Nashville

Local Institution, Dallas

Local Institution, Houston

Local Institution, Buenos Aires

Local Institution, Córdoba

Local Institution, St Leonards

Local Institution, South Brisbane

Local Institution, East Melbourne

Local Institution, Parkville

Local Institution, Wien

Local Institution, B-Leuven

Local Institution, Edegem

Local Institution, Rio de Janeiro

Local Institution, São Paulo

Local Institution, Campinas

Local Institution, Toronto

Local Institution, Aarhus

Local Institution, Helsinki

Local Institution, Lille

Local Institution, Lyon

Local Institution, Nantes

Local Institution, Paris

Local Institution, Pessac

Local Institution, Poitiers

Local Institution, Strasbourg

Local Institution, Hamburg

Local Institution, Mainz

Local Institution, Mannheim

Local Institution, Ramat Gan

Local Institution, Bologna

Local Institution, Napoli

Local Institution, Orbassano

Local Institution, Roma

Local Institution, Nijmegen

Local Institution, Rotterdam

Local Institution, Trondheim

Local Institution, Lima

Local Institution, Quezon City

Local Institution, Singapore

Local Institution, Jeollanam-Do

Local Institution, Kyunggi-Do

Local Institution, Seoul

Local Institution, Gothenburg

Local Institution, Lund

Local Institution, Umeå

Local Institution, Uppsala

Local Institution, Basel

Local Institution, Taipei

Local Institution, Taoyuan District

Local Institution, Bangkok

Local Institution, Glasgow

Local Institution, London